Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Shanghai Pharma Denies Probe Report, Says Deals Complied
Bloomberg
Thursday, May 24, 2012 - 10:35am
tags:
Shanghai Pharmaceutical
Pfizer Launches Lipitor Mobile App
Marketing Daily
Thursday, May 24, 2012 - 10:34am
tags:
Pfizer, Lipitor, mobile apps
Glaxo Avoids Market For Lemons By Buying Collaborators
Bloomberg
Thursday, May 24, 2012 - 10:27am
tags:
GSK, M&A, Human Genome Sciences, Theravance, diaDexus
Breathe Deeply: Safety Concerns Over Spiriva
Pharmalot
Thursday, May 24, 2012 - 10:15am
tags:
Spiriva, Boehringer Ingelheim, COPD
Zalicus Is Locked And Loaded: What You Need To Know
Seeking Alpha
Thursday, May 24, 2012 - 10:14am
tags:
Zalicus, Synavive, rheumatoid arthritis
Teva Pharm cuts 2012 sales, profit outlook
Reuters
Thursday, May 24, 2012 - 10:13am
tags:
Teva Pharmaceuticals, guidance
Nexavar: Are 3 Failed Phase 3 Trials Enough?
Motley Fool
Thursday, May 24, 2012 - 10:13am
tags:
Bayer, Onyx, Nexavar, lung cancer
Eli Lilly announces Phase 3 study results for linagliptin
The Fly on the Wall
Thursday, May 24, 2012 - 10:01am
tags:
Eli Lilly, linagliptin, diabetes
J&J's Xarelto likely delayed 3-12 months, not dead, says Leerink
The Fly on the Wall
Thursday, May 24, 2012 - 9:43am
tags:
bloodthinner, JNJ, Xarelto
MediciNova asthma drug fails trial; shares crash
Reuters
Wednesday, May 23, 2012 - 7:00pm
tags:
asthma, MedicNova, MN-221
New CEO takes the helm at biotech giant Amgen
Yahoo/AP
Wednesday, May 23, 2012 - 6:59pm
tags:
Amgen, Kevin Sharer, Bob Bradway
FDA panel votes against new use for J&J's Xarelto
Yahoo/AP
Wednesday, May 23, 2012 - 6:58pm
tags:
FDA, advisory panel, Xarelto, bloodthinners, JNJ
Dendreon: Analyst Sees “Epic” Price, Competition Challenges
Barron's
Wednesday, May 23, 2012 - 6:57pm
tags:
Dendreon, prostate cancer, Provenge
Merck CEO assures shareholders there is life after death of Singulair patent
Fierce Pharma
Wednesday, May 23, 2012 - 12:32pm
tags:
Singulair, patents, Merck, Pharma CEOs, Kenneth Frazier, Januvia, Victrelis
Sequenom's Brief, Wondrous Agreement
Motley Fool
Wednesday, May 23, 2012 - 12:20pm
tags:
Sequenom, MaterniT21
Weighing The Benefits Of Osiris' First Cell Therapy Approval
Seeking Alpha
Wednesday, May 23, 2012 - 12:19pm
tags:
stem cells, Osiris, Advanced Cell Technologies, Aastrom Biosciences, NeoStem, JNJ, Dendreon, Prochymal
AVEO Oncology initiates Phase 1 study of AV-203
Yahoo
Wednesday, May 23, 2012 - 12:10pm
tags:
Aveo, AV-203, cancer, monoclonal antibodies
GSK to drop Human Genome bid if "poison pill" stands
Yahoo/Reuters
Wednesday, May 23, 2012 - 12:09pm
tags:
Human Genome Sciences, GSK, M&A, poison pill
Abbott’s New Use for Top Drug Humira Delayed by U.S.
Bloomberg Businessweek
Wednesday, May 23, 2012 - 12:06pm
tags:
Humira, Abbott Laboratories, FDA, ulcerative colitis
Study highlights cardio safety of Lilly GLP-1 dulaglutide
Pharma Times, UK
Wednesday, May 23, 2012 - 12:05pm
tags:
Eli Lilly, dulaglutide, diabetes

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.